Literature DB >> 33802197

Digestive Inflammation: Role of Proteolytic Dysregulation.

Vincent Mariaule1, Aicha Kriaa1, Souha Soussou1, Soufien Rhimi1, Houda Boudaya1, Juan Hernandez2, Emmanuelle Maguin1, Adam Lesner3, Moez Rhimi1.   

Abstract

Dysregulation of the proteolytic balance is often associated with diseases. Serine proteases and matrix metalloproteases are involved in a multitude of biological processes and notably in the inflammatory response. Within the framework of digestive inflammation, several studies have stressed the role of serine proteases and matrix metalloproteases (MMPs) as key actors in its pathogenesis and pointed to the unbalance between these proteases and their respective inhibitors. Substantial efforts have been made in developing new inhibitors, some of which have reached clinical trial phases, notwithstanding that unwanted side effects remain a major issue. However, studies on the proteolytic imbalance and inhibitors conception are directed toward host serine/MMPs proteases revealing a hitherto overlooked factor, the potential contribution of their bacterial counterpart. In this review, we highlight the role of proteolytic imbalance in human digestive inflammation focusing on serine proteases and MMPs and their respective inhibitors considering both host and bacterial origin.

Entities:  

Keywords:  digestive inflammation; gut microbiota; holobiont; protease; serpin

Mesh:

Substances:

Year:  2021        PMID: 33802197      PMCID: PMC7999743          DOI: 10.3390/ijms22062817

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  162 in total

Review 1.  Proteases and the gut barrier.

Authors:  Paolo Biancheri; Antonio Di Sabatino; Gino R Corazza; Thomas T MacDonald
Journal:  Cell Tissue Res       Date:  2012-03-20       Impact factor: 5.249

2.  Design of Potent and Selective Cathepsin G Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold.

Authors:  Joakim E Swedberg; Choi Yi Li; Simon J de Veer; Conan K Wang; David J Craik
Journal:  J Med Chem       Date:  2017-01-18       Impact factor: 7.446

3.  The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin.

Authors:  C L Scudamore; M A Jepson; B H Hirst; H R Miller
Journal:  Eur J Cell Biol       Date:  1998-04       Impact factor: 4.492

4.  A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-Tryptase.

Authors:  Sarah F Giardina; Douglas S Werner; Maneesh Pingle; Donald E Bergstrom; Lee D Arnold; Francis Barany
Journal:  Pharmacology       Date:  2018-08-22       Impact factor: 2.547

5.  Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.

Authors:  Mohammed Salah Ayoup; Manar Ahmed Fouad; Hamida Abdel-Hamid; El Sayed Ramadan; Marwa M Abu-Serie; Ahmed Noby; Mohamed Teleb
Journal:  Eur J Med Chem       Date:  2019-11-10       Impact factor: 6.514

6.  Miropin, a novel bacterial serpin from the periodontopathogen Tannerella forsythia, inhibits a broad range of proteases by using different peptide bonds within the reactive center loop.

Authors:  Miroslaw Ksiazek; Danuta Mizgalska; Jan J Enghild; Carsten Scavenius; Ida B Thogersen; Jan Potempa
Journal:  J Biol Chem       Date:  2014-11-11       Impact factor: 5.157

7.  Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration.

Authors:  Bastien Hermant; Stephanie Bibert; Evelyne Concord; Bernard Dublet; Marianne Weidenhaupt; Thierry Vernet; Danielle Gulino-Debrac
Journal:  J Biol Chem       Date:  2003-02-12       Impact factor: 5.157

8.  Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulant-anticoagulant equilibrium toward thrombosis.

Authors:  Giulia Pontarollo; Laura Acquasaliente; Daniele Peterle; Roberta Frasson; Ilaria Artusi; Vincenzo De Filippis
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

Review 9.  Protease inhibition as new therapeutic strategy for GI diseases.

Authors:  Nathalie Vergnolle
Journal:  Gut       Date:  2016-04-12       Impact factor: 23.059

10.  The effect of environmental conditions on expression of Bacteroides fragilis and Bacteroides thetaiotaomicron C10 protease genes.

Authors:  Roibeard F Thornton; Elizabeth C Murphy; Todd F Kagawa; Paul W O'Toole; Jakki C Cooney
Journal:  BMC Microbiol       Date:  2012-09-03       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.